Acute Myeloid Leukemia: Significance of the Skin Test

Yavuz Yagar¹, Mehmet Ali Erkurt², Ilhami Berber², Ilknur Nizam^2, , Mustafa Koroglu², Haci Bayram Berktas¹, Engin Burak Selcuk³, Emin Kaya² and Irfan Kuku²

¹Department of Internal Medicine, Faculty of Medicine, Inonu University, Malatya, Turkey

²Department of Hematology, Faculty of Medicine, Inonu University, Malatya, Turkey

³Department of Family Medicine, Faculty of Medicine, Inonu University, Malatya, Turkey

Cite this paper:
Yavuz Yagar, Mehmet Ali Erkurt, Ilhami Berber, Ilknur Nizam, Mustafa Koroglu, Haci Bayram Berktas, Engin Burak Selcuk, Emin Kaya and Irfan Kuku. Acute Myeloid Leukemia: Significance of the Skin Test. American Journal of Medical Case Reports. 2014; 2(3):55-56. doi: 10.12691/ajmcr-2-3-4

Abstract

Granulocytic sarcoma is generally associated to acute myeloblastic leukemia, either as its first clinical manifestation, tissue expression of the disease, or initial symptom of its recurrence. Less than 1 percent of patients will present with prominent extramedullary disease (i.e., myeloid sarcoma, also called granulocytic sarcoma, myeloblastoma, or chloroma). We report the case of a young patient suffering from granulocytic sarcoma of her right ankle which is symptom of its recurrence.

Keywords:
granulocytic sarcoma dermatological symptoms ankle knee acute myeloid leukemia

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Büchner Th, Saußele S, Hehlmann R. Akute und chronischemyeloische Leukämie. In: Dietel M, Suttorp N, Zeitz M: Harrisons Innere Medizin Band 1. Berlin: ABW? Wissenschaftsverlag, 2009: 845-56.
[2]	Pezzutto A, Dörken B. Neoplasiendes lymphatischen Systems. In: Dietel M, Suttorp N, Zeitz M: Harrisons Innere Medizin Band 1. Berlin: ABW? Wissenschaftsverlag, 2009: 857-73.
[3]	Swerdlow SH, Campo E, Harris NL, et al. World Health Organization (WHO) Classification of Tumours of Haematopoietic.
[4]	Jänner M. Hämoblastosen der Haut. In: Korting GW: Dermatologie in Praxisund Klinik. Stuttgart: Thieme, 1981: 39. 339. 26.
[5]	Ratnam KV, Khor CJL, Su WPD. Leukemia cutis. Dermatol Clin 1994; 12: 419-31.
[6]	Dores GM, Devesa SS, Curtis RE, et al. Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood 2012; 119: 34.
[7]	B. Lee, G. M. Fatterpekar, W. Kim, and P. M. Som, “Granulocytic sarcoma of the temporal bone,”American Journal of Neuro radiology, vol. 23, no. 9, pp. 1497-1499, 2002. View at Scopus.
[8]	R. S. Neiman, M. Barcos, and C. Berard, “Granulocytic sarcoma: a clinico pathologic study of 61 biopsied cases,” Cancer, vol. 48, no. 6, pp. 1426-1437, 1981. View at Scopus.
[9]	Yamauchi K, Yasuda M. Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature. Cancer 2002; 94: 1739.
[10]	Byrd JC, Edenfield WJ, Shields DJ, Dawson NA. Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review. J ClinOncol 1995; 13: 1800.
[11]	Paydas S, Zorludemir S, Ergin M. Granulocyticsarcoma: 32 cases and review of the literature. LeukLymphoma 2006; 47: 2527.